Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Ana P. Goncalvez"'
Autor:
Irina V. Ustyugova, Svetlana Pougatcheva, Timothy Farrell, Tod Strugnell, Vardhini Ganesh, Konstantin B. Zeldovich, Sudha Chivukula, Ana P. Goncalvez, Mario Barro
Publikováno v:
Vaccine. 41:2022-2034
Autor:
Nicolas Jackson, Francisco Maldonado-Arocho, Valerie Lecouturier, Ana P. Goncalvez, Raul C. Gomila, Harold Kleanthous, Diaz Fernando Martin, Nicolas Burdin, John Catalan, Maryann Giel-Moloney, Simon Delagrave, Ray Oomen, Konstantin V. Pugachev, Jon Heinrichs, Marie-Clotilde Bernard, Yves Girerd-Chambaz
Publikováno v:
Scientific Reports
Scientific Reports, Vol 8, Iss 1, Pp 1-11 (2018)
Scientific Reports, Vol 8, Iss 1, Pp 1-11 (2018)
Zika virus (ZIKV) is an emerging mosquito-borne pathogen representing a global health concern. It has been linked to fetal microcephaly and other birth defects and neurological disorders in adults. Sanofi Pasteur has engaged in the development of an
Autor:
Leonid V. Chernomordik, Félix A. Rey, Stéphane Duquerroy, Ana P. Goncalvez, M. Erika Navarro Sanchez, Philippe Dussart, Elena Zaitseva, Carlos M. Kikuti, Joseph J.B. Cockburn, Enrico A. Stura, Ching-Juh Lai
Publikováno v:
The EMBO Journal. 31:767-779
The four serotypes of dengue virus (DENV-1 to -4) cause the most important emerging viral disease. Protein E, the principal viral envelope glycoprotein, mediates fusion of the viral and endosomal membranes during virus entry and is the target of neut
Autor:
Ana P. Goncalvez, Syd Johnson, Michael S. Diamond, Olivia K. T. Block, Xia Jin, Ching Juh Lai, Jacob J. Schlesinger, Robert C. Rose, Soila Sukupolvi-Petty, Christopher Lane, W. W. Shanaka I. Rodrigo
Publikováno v:
Virology. 394(2):175-182
Severe dengue virus (DENV) infection is epidemiologically linked to pre-existing anti-DENV antibodies acquired by maternal transfer or primary infection. A possible explanation is that DENV immune complexes evade neutralization by engaging Fcgamma re
Autor:
Claire Wernly, Ching-Juh Lai, Ruhe Men, Robert H. Purcell, Olivia K. Donau, Ana P. Goncalvez, Ronald E. Engle
Publikováno v:
Journal of Virology. 81:12766-12774
The chimpanzee monoclonal antibody (MAb) 5H2 is specific for dengue virus type 4 (DENV-4) and neutralizes the virus at a high titer in vitro. The epitope detected by the antibody was mapped by sequencing neutralization escape variants of the virus. O
Publikováno v:
Proceedings of the National Academy of Sciences
Infection with dengue virus (DENV) or any other flavivirus induces cross-reactive, but weakly neutralizing or nonneutralizing, antibodies that recognize epitopes involving the fusion peptide in the envelope glycoprotein. Humanized mAb IgG 1A5, derive
Publikováno v:
Journal of Virology. 78:12919-12928
The epitope determinants of chimpanzee Fab antibody 1A5, which have been shown to be broadly reactive to flaviviruses and efficient for cross-neutralization of dengue virus type 1 and type 2 (DENV-1 and DENV-2), were studied by analysis of DENV-2 ant
Autor:
Harry Kleanthous, Maryann Giel-Moloney, Yuxi Liu, John Catalan, Alexander A. Rumyantsev, Jeff Almond, Konstantin V. Pugachev, Qing-sheng Gao, Ana P. Goncalvez
Tick-borne encephalitis (TBE) virus is the most important human pathogen transmitted by ticks in Eurasia. Inactivated vaccines are available but require multiple doses and frequent boosters to induce and maintain immunity. Thus far, the goal of devel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5db3201c1b62f60842b71b9fdb65930
https://europepmc.org/articles/PMC3740852/
https://europepmc.org/articles/PMC3740852/
Autor:
Inna Gorshkova, Ching-Juh Lai, Carrie Roll, Cheng-Hsin Chien, Ana P. Goncalvez, Sutee Yoksan, Sy-Dar Wang, Kamolchanok Tubthong, Peter Schuck, Robert H. Purcell, Olivia K. Donau
Japanese encephalitis virus (JEV)-specific Fab antibodies were recovered by repertoire cloning from chimpanzees initially immunized with inactivated JE-VAX and then boosted with attenuated JEV SA14-14-2. From a panel of 11 Fabs recovered by different
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e85109171145585ed0be5905a9249ace
https://europepmc.org/articles/PMC2446956/
https://europepmc.org/articles/PMC2446956/
Autor:
Claire Wernly, Ana P. Goncalvez, Suzanne U. Emerson, Darren J. Schofield, Ruhe Men, Ching-Juh Lai, Tetsu Yamashiro, Robert H. Purcell
Publikováno v:
Journal of virology. 78(9)
A safe and effective dengue vaccine is still not available. Passive immunization with monoclonal antibodies from humans or nonhuman primates represents an attractive alternative for the prevention of dengue virus infection. Fab monoclonal antibodies